Manufacturer
GLAXO WELLCOME S.A.
Contents
Ranitidine HCl
Indication
NSAID-associated duodenal & benign gastric ulcer. Post-op ulcer. Oesophageal reflux. Zollinger-Ellison syndrome. Prophylaxis of stress ulceration in seriously ill patients, recurrent haemorrhage from peptic ulcer & Mendelson's syndrome. Tab/syr H pylori-associated duodenal ulcer. Symptomatic relief in GERD. Chronic episodic dyspepsia. Prevention of NSAID-associated duodenal ulcers especially in patients w/ history of peptic ulcer disease.
Instruction
May be taken with or without food.
Drug interaction
Altered prothrombin time w/ coumarin anticoagulants eg, warfarin. Increased plasma levels of procainamide & N-acetylprocainamide. Increased absorption of triazolam, midazolam, glipizide. Decreased absorption of ketoconazole, atazanavir, delaviridine, gefitnib. Reduced absorption by high-dose sucralfate.
Malaysia
